2024 NOSCM | Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cancer (YES)
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Lajos Puzstai, MD, DPhil, FASCO
Disclosure
Lajos Puzstai, MD, DPhil, FASCO discloses no such relationships exist
Accreditation
NA
-1773064384760.webp&w=3840&q=75)
-1773063945796.webp&w=3840&q=75)